Company / Return on Assets (ROA)
TherapeuticsMD, Inc. Return on Assets (ROA) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-26.5%
FY2024
5-year range
-190.6% / 258.6%
FY2020-FY2024
Trend
-110.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -190.6% in FY2022 to 258.6% in FY2023.
Based on SEC 10-K filings.
-26.5% in FY2024 with a 5-year CAGR of +2.5%.
Improved from -190.6% to -26.5% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +77.5pp
- 5-Year Change
- +2.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, return on assets (roa) decreased 110.2% year-over-year.
- Peak return on assets (roa) was recorded in FY2023.
- Lowest return on assets (roa) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -26.5% | -110.2% |
| FY2023 | 258.6% | +235.7% |
| FY2022 | -190.6% | -83.4% |
| FY2021 | -103.9% | -42.3% |
| FY2020 | -73.0% | -152.5% |
| FY2019 | -28.9% | +31.8% |
| FY2018 | -42.4% | +28.6% |
| FY2017 | -59.4% | -56.1% |
| FY2016 | -38.0% | +1.3% |
| FY2015 | -38.6% | +35.2% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026